Active Ingredient: FLUOXETINE HYDROCHLORIDE; OLANZAPINE
Proprietary Name: OLANZAPINE AND FLUOXETINE HYDROCHLORIDE
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: EQ 25MG BASE;EQ 3MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A202074
Product Number: 001
Approval Date: Mar 25, 2013
Applicant Holder Full Name: TEVA PHARMACEUTICALS USA
Marketing Status:
Prescription
Patent and Exclusivity Information
